Literature DB >> 21603826

Marjolin's ulcer associated with ulceration and chronic osteomyelitis.

Ermelindo Tavares1, Gonçalo Martinho, José Alberto Dores, Frederico Vera-Cruz, Luís Ferreira.   

Abstract

This report describes a 78-year old male patient with a chronic venous ulcer on his left leg for the past 24 years, complicated by a squamous-cell carcinoma. After staging of the disease, the treatment administered was amputation of the leg above the knee. Marjolin's ulcer consists of the malignant transformation of a chronic ulcerative lesion. It is a relatively rare phenomenon. The malignant tumor most commonly described in the literature is squamous cell carcinoma, followed by basal-cell carcinoma, sarcoma and melanoma. The pathogenesis of Marjolin's ulcer remains to be fully clarified.

Entities:  

Mesh:

Year:  2011        PMID: 21603826     DOI: 10.1590/s0365-05962011000200026

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  4 in total

1.  Ten years of experience in chronic ulcers and malignant transformation.

Authors:  Maria G Onesti; Pasquale Fino; Paolo Fioramonti; Vittoria Amorosi; Nicolò Scuderi
Journal:  Int Wound J       Date:  2013-07-19       Impact factor: 3.315

Review 2.  Post-burn scar malignancy: 5-year management review and experience.

Authors:  Ahmed K Mousa; Anwar A Elshenawy; Salah M Maklad; Shaimaa M M Bebars; Hisham A Burezq; Sherif E Sayed
Journal:  Int Wound J       Date:  2021-09-18       Impact factor: 3.099

3.  Clinical characteristics, treatment, and prognosis of squamous cell carcinoma arising from extremity chronic osteomyelitis: a synthesis analysis of one hundred and seventy six reported cases.

Authors:  Nan Jiang; Su-Yi Li; Ping Zhang; Bin Yu
Journal:  Int Orthop       Date:  2020-07-23       Impact factor: 3.075

4.  Marjolin's Ulcer Presenting with In-Transit Metastases: A Case Report and Literature Review.

Authors:  Ilknur Altunay; Asli Aksu Çerman; Damlanur Sakiz; Bilge Ates
Journal:  Ann Dermatol       Date:  2015-07-29       Impact factor: 1.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.